Complexation Study of the Anticancer Agent EO-9 with 2-hydroxypropyl-β-Cyclodextrin

By Beijnen J. H.   van der Schoot S. C.   Nuijen B.   Flesch F. M.   Gore A.   Mirejovsky D.   Lenaz L.  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 10, 2008-10 ,pp. : 1130-1139

Informa Healthcare

Access to resources Recommend Favorite

Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin

By Guo Bohong   Zhong Shufen   Li Niying   Li Xiaofang   Yi Jun   Jin Miaozhen  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 11, 2013-11 ,pp. : 1638-1643

Informa Healthcare

Access to resources Recommend Favorite

Development of an Omeprazole Parenteral Formulation with Hydroxypropyl-β-Cyclodextrin

By Holvoet Chantal   Heyden Yvan Vander   Plaizier-Vercammen Jacqueline  

Pharmaceutical Development and Technology, Vol. 12, Iss. 3, 2007-05 ,pp. : 327-336

Informa Healthcare

Access to resources Recommend Favorite

Inclusion complexes of fluorofenidone with β-cyclodextrin and hydroxypropyl-β-cyclodextrin

By Wang Shengfeng   Ding Yanfei   Yao Yao  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 7, 2009-07 ,pp. : 808-813

Informa Healthcare

Access to resources Recommend Favorite

Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique

By Chen Zhongjian   Lu Yi   Qi Jianping   Wu Wei  

Pharmaceutical Development and Technology, Vol. 18, Iss. 1, 2013-02 ,pp. : 130-136

Informa Healthcare

Access to resources Recommend Favorite